<DOC>
	<DOCNO>NCT00704782</DOCNO>
	<brief_summary>The purpose study assess safety efficacy Dimebon combination donepezil ( Aricept ) treatment Alzheimer 's disease .</brief_summary>
	<brief_title>Study Combination Therapy With Dimebon Donepezil ( Aricept ) Patients With Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Alzheimer 's disease On donepezil ( Aricept ) Caregiver care patient least 5 day per week Unstable medical illness significant hepatic renal disease Other primary psychiatric neurological disorder</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>